BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10738763)

  • 1. [Posthemorrhagic cerebral vasospasm in light of the current concepts on the regulation of cerebral blood circulation].
    Karpiuk VB; Cherniak IuS; Shubin MG
    Zh Vopr Neirokhir Im N N Burdenko; 2000; (1):30-3; discussion 34. PubMed ID: 10738763
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelin receptor antagonists and cerebral vasospasm.
    Zimmermann M; Seifert V
    Clin Auton Res; 2004 Jun; 14(3):143-5. PubMed ID: 15241641
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebral vascular changes during chronic hypertension: good guys and bad guys.
    Heistad DD; Baumbach GL
    J Hypertens Suppl; 1992 Dec; 10(7):S71-5. PubMed ID: 1291659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etomidate, nitric oxide, and cerebral vasospasm.
    Mashour GA
    Anesth Analg; 2008 Jul; 107(1):343; author reply 343-4. PubMed ID: 18635509
    [No Abstract]   [Full Text] [Related]  

  • 5. Endothelins and the cerebral circulation.
    Salom JB; Torregrosa G; Alborch E
    Cerebrovasc Brain Metab Rev; 1995; 7(2):131-52. PubMed ID: 7669492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm.
    Cirak B; Kiymaz N; Ari HH; Ugras S
    Clin Auton Res; 2004 Jun; 14(3):197-201. PubMed ID: 15241650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
    Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
    Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed cerebral vasospasm and nitric oxide: review, new hypothesis, and proposed treatment.
    Pluta RM
    Pharmacol Ther; 2005 Jan; 105(1):23-56. PubMed ID: 15626454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage.
    Suhardja A
    Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):110-6; quiz 2 p following 116. PubMed ID: 16265315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associated with cerebral vasospasm after subarachnoid haemorrhage in rabbits.
    Neuschmelting V; Marbacher S; Fathi AR; Jakob SM; Fandino J
    Acta Neurochir (Wien); 2009 Jul; 151(7):795-801; discussion 801-2. PubMed ID: 19415172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin receptor antagonists and cerebral vasospasm: an update.
    Chow M; Dumont AS; Kassell NF
    Neurosurgery; 2002 Dec; 51(6):1333-41; discussion 1342. PubMed ID: 12445337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the cerebral circulation by endothelium.
    Faraci FM
    Pharmacol Ther; 1992; 56(1):1-22. PubMed ID: 1297144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide metabolites in cisternal CSF correlate with cerebral vasospasm in patients with a subarachnoid haemorrhage.
    Woszczyk A; Deinsberger W; Böker DK
    Acta Neurochir (Wien); 2003 Apr; 145(4):257-63; discussion 263-4. PubMed ID: 12748885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Endothelins].
    Bornkessel B
    Med Monatsschr Pharm; 1996 Mar; 19(3):66-8. PubMed ID: 8868963
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebral blood flow regulation by nitric oxide: recent advances.
    Toda N; Ayajiki K; Okamura T
    Pharmacol Rev; 2009 Mar; 61(1):62-97. PubMed ID: 19293146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemomechanics of cerebral vasospasm and its resolution: II. Constitutive relations and model simulations.
    Baek S; Valentín A; Humphrey JD
    Ann Biomed Eng; 2007 Sep; 35(9):1498-509. PubMed ID: 17487585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: putative mechanisms and novel approaches.
    Kolias AG; Sen J; Belli A
    J Neurosci Res; 2009 Jan; 87(1):1-11. PubMed ID: 18709660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of endothelial-derived relaxing factors in the regulation of cerebral blood flow.
    Qi M; Hang C; Zhu L; Shi J
    Neurol Sci; 2011 Aug; 32(4):551-7. PubMed ID: 21584736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
    Udoetuk JD; Stiefel MF; Hurst RW; Weigele JB; LeRoux PD
    Neurosurgery; 2007 Dec; 61(6):1152-9; discussion 1159-61. PubMed ID: 18162893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of transcranial Doppler in optimizing treatment of cerebral vasospasm in subarachnoid hemorrhage.
    Darwish RS; Ahn E; Amiridze NS
    J Intensive Care Med; 2008; 23(4):263-7. PubMed ID: 18480082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.